The global beta glucan market was valued at approximately USD 569.8 million in 2022 and is expected to experience a robust growth rate, with a compound annual growth rate (CAGR) of 8.0% from 2023 to 2030. This growth is primarily driven by the increasing use of beta glucan as an immunity booster in the pharmaceutical and nutraceutical industries. Beta glucan is known for its ability to strengthen the immune system, and its incorporation into products aimed at improving health is a significant factor in the market’s expansion.
Alongside this, there is a growing trend in consumer preferences shifting towards the use of nutritious food supplements rather than synthetic ingredients. This shift is part of a broader movement towards health-conscious eating, where consumers are increasingly aware of the benefits of natural, plant-based, and functional ingredients. As a result, products containing beta glucan, which is often sourced from grains like oats and barley, are gaining popularity as people seek healthier alternatives to traditional supplements or pharmaceuticals.
The market is also benefiting from heightened awareness among manufacturers about the importance of utilizing a diverse range of sources for beta glucan, as well as experimenting with different harvesting, processing, and extraction techniques. These methods aim to improve the efficacy and quality of beta glucan while expanding its applications. Manufacturers are increasingly investing in innovative patented technologies to enhance product performance, improve market share, and drive sales. By using cutting-edge technology, companies can create more effective products that meet the evolving needs of health-conscious consumers, which is expected to boost overall market growth.
Gather more insights about the market drivers, restrains and growth of the Beta-Glucan Market
Regional Insights
Europe
In 2022, Europe dominated the beta glucan market, accounting for the largest revenue share of 36.6%. The region’s strong market position is driven by several key factors, including the presence of numerous major players in the market. These companies benefit from high disposable incomes in Europe, allowing for greater consumer spending on health-related products, particularly nutraceutical supplements that contain beta glucan. The growing trend of health and wellness among European consumers, along with a shift towards natural, functional foods, is expected to continue driving the demand for beta glucan products in the region.
Moreover, the rising awareness of the benefits of beta glucan in boosting immunity and promoting overall health has encouraged European consumers to increasingly incorporate these products into their diets. Companies in the region are also focusing on innovative manufacturing techniques to produce customized products specifically tailored for different end-use industries such as pharmaceuticals, food, and beverages, as well as cosmetics. These innovations, along with ongoing advancements in extraction methods, are likely to play a pivotal role in sustaining the growth of the beta glucan market in Europe over the next eight years.
Asia Pacific
The Asia Pacific region is projected to witness the fastest CAGR of 9.5% during the forecast period from 2023 to 2030. This rapid growth can be attributed to the region’s increasing focus on nutraceuticals, coupled with a significant expansion of consumer industries in countries like China, India, and Japan. As the region becomes more health-conscious, there is a growing adoption of dietary supplements and functional foods that enhance wellness, immune function, and overall vitality.
China is expected to lead the demand for beta glucan consumption and production in the region due to its large population, expanding middle class, and increasing awareness about the benefits of natural, plant-based supplements. As the country’s healthcare and wellness sectors continue to grow, beta glucan is likely to become a key ingredient in the dietary supplements market. The adoption of Western-style dietary habits, such as consuming more functional foods and fortified products, is further driving the demand for beta glucan in the Asia Pacific region.
Browse through Grand View Research's Nutraceuticals & Functional Foods Industry Research Reports.
• The global black tea extracts market size was valued at USD 8.09 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.3% from 2024 to 2030.
• The global fermented ingredients market size was valued at USD 35.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2030.
Key Companies & Market Share Insights
The beta glucan market is highly competitive, with numerous global manufacturers holding a significant share of the market. These companies use a range of strategic business tactics, including product launches, approvals, strategic acquisitions, and innovations, to maintain and expand their global market reach. Innovation is a key driver in this industry, as companies continually seek to improve the efficacy, bioavailability, and formulation of beta glucan products to meet the needs of a more health-conscious and well-informed consumer base.
Key Beta Glucan Companies:
Several key players lead the global beta glucan market, accounting for a significant portion of the market share. These companies are recognized for their contributions to the development, production, and innovation of beta glucan products. Notable companies in the market include:
• Biotec Pharmacon ASA
• Biothera Pharmaceuticals
• Ceapro Inc.
• Immunomedics
• Super Beta Glucan Inc.
• DSM NV
• Tate & Lyle plc (Tate & Lyle Oat Ingredients)
• Groupe Soufflet SA (AIT Ingredients)
• Zilor Inc. (Biorigin)
• Cargill Incorporated
• Frutarom
• GlycaNova AS
• Lesaffre Human Care
• Garuda International, Inc.
• Millipore Sigma
Order a free sample PDF of the Beta-Glucan Market Intelligence Study, published by Grand View Research.